“Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A proof-of-concept study”, Rev Alerg Mex, vol. 65, no. 1, pp. 41–51, Apr. 2018, doi: 10.29262/ram.v65i1.322.